NS
Insider
Novo Holdings A/S
10% ownerNovo Holdings A/S (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in AVLN. Across 1 priced purchase filing, the average 21-session return was -4.8% from execution and -10.0% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of AVLN (555,555 sh × $18.00, as filed), executed May 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-4.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-10.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.0M
shares × price, as filed
Last traded
May 1
Filed May 5
Median ADV $7.7M across their filed names
Open performance→Volume by month
Buys $26.2M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Most traded names
AVLN
AVLN
1 buy · 0 sells
1 filing
MPLTRecent filings
AVLNPURCHASE
Avalyn Pharma Inc.
View filing →
$10.0M555,555 sh × $18.00
Exec May 1
Filed May 5 · 4:15 PM ET MPLTPURCHASE MapLight Therapeutics, Inc. View filing → $16.2M
952,941 sh × $17.00
Exec Oct 28 2025
Filed Oct 30 2025 · 4:31 PM ET